Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 7,375

Document Document Title
WO/2021/031984A1
Disclosed are a carboxylic acid oxime ester compound and the use thereof as a herbicide and for preparing a microbicide. The carboxylic acid oxime ester compound is as represented by general formula I:  
WO/2021/035176A1
The invention provides a compound of formula (I): wherein R1, R2, and R3 have any of the values described in the specification, as well as compositions comprising a compound of formula (I), methods for preparing compounds of formula (I),...  
WO/2021/023144A1
Disclosed in the present invention is a novel fluorenoxime ester compound, a preparation method therefor, a photoinitiator containing the fluorenoxime ester compound, and a photosensitive resin composition. The fluorenoxime ester compoun...  
WO/2021/009026A1
Compounds of formula (I): (Formula (I)) Formula (I) encompasses e.g. tetraline, chromane, isochromane, 6,7,8,9-tetrahydrobenzo[7]annulene, 1H-isobenzofurane and indane derivatives. The compounds of formula (I) are useful as a pesticides,...  
WO/2020/262648A1
The present invention provides a compound that has an excellent pest-controlling effect and that is represented by formula (I) [in the formula, L represents an oxygen atom or CH2, E represents a C2-C10 chain hydrocarbon group or the like...  
WO/2020/258971A1
Provided are a new class of hydrazone amide derivatives and the use thereof in the preparation of anti-osteoporosis drugs, wherein the structural formula of the hydrazone amide derivative is as shown in formula (I), and same are a new cl...  
WO/2020/245468A1
The present invention relates to compounds useful as modulators of sirtuins, in particular as activators of SIRT1. Furthermore, the invention refers to the medical use of such compounds, in particular in the prevention and/or treatment o...  
WO/2020/240391A1
The present invention discloses an improved process for the preparation of bromo-formimine compounds. More particularly, the present invention discloses an improved process for the preparation of bromo-formimine compounds, wherein bromin...  
WO/2020/234128A1
The invention concerns a process for preparing an aldol ester of the formula (I), characterized in that at least one carboxylic anhydride of the formula (II) is reacted with at least one aldol of the formula (III) with heating in the pre...  
WO/2020/237079A1
In alternative embodiments, provided are uncharged bis-oxime antidotes that cross the blood-brain barrier (BBB) to catalyze the hydrolysis of organophosphate (OP)-inhibited human acetylcholinesterase (hAChE) in the central nerve system (...  
WO/2020/234069A1
The disclosure relates to 1-(bicyclo[2.2.1]hept-5-en-2-yl)ethan-1-one O-methyl oxime possessing powerful green fruity anisic banana olfactory properties. The invention furthermore refers to fragrance compositions comprising it and to a m...  
WO/2020/214095A1
The present invention relates to, in general, methods of fabricating a covalent organic framework (COF) and the COF thereof. In particular, the method comprises forming an acylhydrazone bond with an optionally substituted 2-alkoxybenzohy...  
WO/2019/236614A8
The synthesis and application of compounds having unique and desired flavor and/or fragrance characteristics are provided herein. The compounds herein can be employed alone or incorporated as fragrance or flavor ingredients in fragrance ...  
WO/2020/202940A1
Provided is a catalytic mixture with sufficient catalytic efficiency, wherein pressure loss is small when the catalytic mixture fills a flow reactor and a reactive solution is caused to flow therethrough, and the catalytic efficiency and...  
WO/2020/193387A1
Compounds of the formula (I) wherein the substituents are as defined in claim 1, useful as a pesticides, especially as fungicides.  
WO/2020/184336A1
Provided is a liquid metal complex having oxygen-absorbing ability and containing: a cobalt acacene complex or a derivative thereof; and an ionic liquid in which an ionic ligand having an amine structure and a counter ion thereof are pai...  
WO/2020/179579A1
A compound having a (1) perovskite crystal structure such that the full width at half maximum of a peak in a plane Miller index (001) of the X-ray diffraction pattern thereof is at least 0.10 and less than 0.60, and comprising a monovale...  
WO/2020/181165A1
Provided herein are compounds of formula (I), compositions comprising the compounds and method of treating various diseases with the compounds and compositions.  
WO/2020/175705A1
[Problem] To provide: a tin-based perovskite layer that is highly purified by the removal of a trace amount of Sn4+ present in a system, the tin-based perovskite layer having good photoelectric conversion efficiency due to not being susc...  
WO/2020/170388A1
To provide a novel production promoter of type I collagen or elastin. A production promoter of type I collagen or elastin that comprises a mycosporine-like amino acid or a salt thereof as an active ingredient.  
WO/2020/169047A1
Disclosed in the present invention is a 1,1-dicyanohydrazone compound having a novel structure, the structure being as shown in general formula I. See the description for the definitions of each substituent in the formula. The compound o...  
WO/2020/152120A1
Disclosed are α-keto oxime ester carbazole derivatives with a specific aroyl chromophore useful as a photo initiator, as well as photopolymerizable compositions comprising said photo initiator and ethylenically unsaturated compounds. Th...  
WO/2020/150639A1
The present disclosure provides therapeutic methods of treating a cancer in a subject with isopropyl (S)-2-((S)-2-acetamido-3-(1H-indol-3-yl)propanamido)-6-diazo -5-oxohexanoate or isopropyl (S)-2-((S)-6-acetamido-2-((3S,5S,7S)-adamantan...  
WO/2020/148617A1
The present invention disclosed 3-substituted phenylamidine compounds of general formula (I), wherein R1, R2, R3, R4, R4a, R4b, A and E have the same meanings as defined in description. The present invention further discloses methods for...  
WO/2020/140924A1
The present invention provides dihydrazone compounds having high affinity to Aβ protein and Tau protein and derivatives thereof. The structure of said compounds is as shown in formula (I): (I). Such compounds can be directly used as flu...  
WO/2020/132819A1
Disclosed is a method for preparing (1R,3S)-3-aminocyclopentanol hydrochloride. The method comprises using amide formed by chiral carboxylic acid and hydroxylamine as a chiral source, quickly obtaining a chiral Diels-Alder reaction produ...  
WO/2020/124557A1
Disclosed are a large steric hindrance asymmetric (α-diimine) nickel olefin catalyst based on vinylidene acenaphthoquinone as a skeleton, and preparation method and application thereof. The structural formula of the large steric hindran...  
WO/2020/124556A1
Disclosed are a large-steric-hindrance asymmetric (alpha-diimine)nickel olefin catalyst based on 1,2-benzoacenaphthenequinone as a skeleton, and a preparation method and an application thereof. The structural formula of the large-steric-...  
WO/2020/130605A1
The present invention relates to a laurolactam preparation method and a synthesis apparatus, and epoxidation and a rearrangement reaction are carried out in the conversion of cyclododecene into cyclododecanone so that the preparation met...  
WO/2020/118307A1
This disclosure provides compositions of SALTAME core containing compounds and associated methods for use in tracking cells by magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and related me...  
WO/2020/100765A1
Provided is a cobalt complex which is liquid at room temperature and useful for manufacturing a cobalt-containing thin film under conditions without using an oxidizing gas. A cobalt complex represented by formula (1). (L1 and L2 repres...  
WO/2020/094928A1
The present disclosure relates to a process for the preparation of 4,5-dihydroxy-2-(4-methylbenzyl)isophthalonitrile, to use of a compound which is 2-methoxy-5-(4-methylbenzyl)phenol, (3-hydroxy-4-methoxyphenyl)(p-tolyl)methanone, 2-meth...  
WO/2020/090658A1
The present invention provides a method for synthesizing a contiguous tetrasubstituted carbon imine compound such as a non-natural amino acid having α, β-contiguous tetrasubstituted carbon atoms, which has an extreme steric hindrance. ...  
WO/2020/082817A1
The present application pertains to the technical field of pharmaceutical compounds and drugs, relates to an oxime-based naphthoquinone compound, a preparation method therefor and the uses thereof, and specifically relates to a formula (...  
WO/2020/078898A1
The present invention provides an improved process for the continuous production of an essentially pure oxime, wherein the oxime is formed by reacting hydroxylamine with an aldehyde or a ketone, wherein the hydroxylamine is formed in an ...  
WO/2020/078884A1
The present invention provides a process for the production of an oxime, the process comprising: a. converting an aldehyde or a ketone by a chemical reaction into an oxime at a temperature of 15 to 115 °C, whereby a reaction mixture com...  
WO/2020/071798A1
[Problem] The present invention provides a compound capable of forming a color filter excellent in heat resistance. [Solution] A compound represented by formula (I), a colored resin composition comprising same, a color filter, and a disp...  
WO/2020/067477A1
The present invention provides an additive for a medium for promoting production of paracrine factors in cells, the additive containing a compound represented by formula (I) or a salt thereof (in the formula, respective characters are as...  
WO/2020/058160A1
The present invention relates to methods for controlling or preventing infestation of cereal plants by the phytopathogenic microorganism Fusarium pseudograminearum, comprising applying to a crop of plants, the locus thereof, or seed ther...  
WO/2020/061367A1
The disclosure features novel lipids and compositions involving the same. Nanoparticle compositions include a novel lipid as well as additional lipids such as phospholipids, structural lipids, and PEG lipids. Nanoparticle compositions fu...  
WO/2020/050368A1
The purpose of the present invention is to provide: a method for preparing a Vilsmeier reagent, that can be carried out safely, easily, and at a low cost; and a method for producing an aromatic aldehyde or an aromatic ketone, a carboxyli...  
WO/2020/035011A1
Provided are a method for preparing 18F-BPA and an intermediate. High-purity 18F-BPA can be obtained by means of the method, which simplifies synthesis steps after 18F labeling, with simple operation and high efficiency.  
WO/2020/018747A1
A method of modulating ribonucleotide reductase activity in a neoplastic cell includes administering to the cell an amount of a hydrazone or hydrazine ribonucleotide reductase modulator (RRmod), the amount being effective to inhibit neop...  
WO/2020/010055A1
A process for the preparation of amino alcohols includes condensing a compound of Formula (II), a stereoisomer, a tautomer, or a salt thereof with a compound of Formula (IlIa) or Formula (Illb), a stereoisomer, a tautomer, or a salt ther...  
WO/2019/236614A1
The synthesis and application of compounds having unique and desired flavor and/or fragrance characteristics are provided herein. The compounds herein can be employed alone or incorporated as fragrance or flavor ingredients in fragrance ...  
WO/2019/235569A1
The present invention addresses the problem of providing: a novel kinase inhibitor and others; and a therapeutic agent for a disease, a drug discovery screening method and others, each utilizing the inhibitor and others. A compound repre...  
WO/2019/230831A1
This method comprises steps: (i) reacting a compound represented by formula (A) with hydrazine to produce a compound represented by formula (B); (ii) reacting the compound represented by formula (B) with formaldehyde to produce a compoun...  
WO/2019/222146A1
In some embodiments of the invention, inventive compounds (e.g., Formula (I), (IA), (II), and (III), and urolithin derivatives) are disclosed. Other embodiments include compositions (e.g., pharmaceutical compositions) comprising the inve...  
WO/2019/221192A1
The present invention provides a method for producing an amino acid aminoalkyl ester or an inorganic acid salt thereof by reacting a compound represented by general formula (I) or a compound represented by general formula (III), or a sal...  
WO/2019/221267A1
Provided are: a novel liquid crystalline compound which can be used in an ionic conductor; an ionic conductor using the liquid crystalline compound; and an electrolytic film and secondary battery using the ionic conductor. This liquid cr...  

Matches 1 - 50 out of 7,375